Sven-Erik Strand
101 – 110 of 184
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
- Contribution to journal › Article
- 2004
-
Mark
Blood pharmacokinetics of various mabs labeled with a new tri-chelating reagent for simultaneous conjugation with DOTA and biotin prior to radiolabeling
(2004) 10th Conference on Cancer Therapy with Antibodies and Immunoconjugates In Cancer Biotherapy and Radiopharmaceuticals 19(4). p.540-541
- Contribution to journal › Published meeting abstract
-
Mark
Dosimetry at 28 keV synchrotron radiation for cell irradiations.
- Contribution to journal › Article
-
Mark
Absorbed dose distribution in glioma tumors in rat brain after therapeutic intratumoral injection of 201Tl-chloride.
- Contribution to journal › Article
-
Mark
Evaluation of parameters influencing s values in mouse dosimetry.
- Contribution to journal › Article
- 2003
-
Mark
Calibration of a radioactive ink-based stack phantom and its applications in nuclear medicine.
- Contribution to journal › Article
-
Mark
Crypt cell dosimetry for 99Tcm-sestamibi in a new small intestinal dosimetry model.
- Contribution to journal › Article
-
Mark
Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
- Contribution to journal › Article
-
Mark
Medical physics e-learning training materials. Information Technology Applications in Biomedicine
(2003) 4th Annual IEEE EMBS Special Topic Conf on Information Technology Applications in Biomedicine, ITAB 2003 p.94-97
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Change in Tumor-absorbed Dose due to Decrease in Mass during Fractionated Radioimmunotherapy in Lymphoma Patients.
- Contribution to journal › Article
